1.               Employment.

    (a)              Employment.  The Company hereby employs ▇▇. ▇▇▇▇▇▇ and ▇▇. ▇▇▇▇▇▇ hereby accepts employment by the Company, subject to the terms set forth in this Agreement.

    (b)              Employment Term.  The term of ▇▇. ▇▇▇▇▇▇’▇ employment under this Agreement (“Employment Term”) shall begin on October 1, 2006 and shall continue for a period of one (1) calendar year, unless terminated sooner in accordance with this Agreement. The Employment Term shall be automatically extended for a successive one-year period unless a notice of non-extension is given by one party to the other at least ninety (90) days prior to the expiration of the then current term.

    (c)              Title and Duties.  ▇▇. ▇▇▇▇▇▇’▇ title shall be Senior Vice President and Chief Operating Officer of the Company, and he shall possess such powers and duties as are normally incident to such position, as he currently exercises and performs and as provided in the By-laws, all in accordance with Utah General Corporation Law. ▇▇. ▇▇▇▇▇▇’▇ title, powers and duties may be changed by the Board of Directors of the Company. During the Employment Term, ▇▇. ▇▇▇▇▇▇ shall faithfully discharge his duties and responsibilities in a diligent manner, devoting substantially all of his working time to the affairs of the Company and its subsidiaries (collectively, “Sento”). ▇▇. ▇▇▇▇▇▇ shall promptly communicate with all members of the Company’s board of directors on all material Company events and matters.

    2.        Compensation and Related Matters.

    (a)              Salary.  For services rendered by ▇▇. ▇▇▇▇▇▇ to Sento and upon the condition that ▇▇. ▇▇▇▇▇▇ fully and faithfully perform all of his duties and obligations owed during the Employment Term under this Agreement. The Company shall pay ▇▇. ▇▇▇▇▇▇ an annual base salary equal to two hundred ten thousand dollars ($210,000), payable in twenty-six equal bi-weekly installments per year less income tax withholdings and other normal employee deductions. The base salary set forth herein shall be reviewed annually by the Compensation Committee (the “Compensation Committee”) of the Board of Directors of the Company at the end of each fiscal year of the Company beginning with the fiscal year ending on or about March 31, 2007 (hereafter “Fiscal Year”), or at such other times as may be deemed appropriate by the Compensation Committee, and may, at the sole discretion of the Compensation Committee, be left unchanged or increased by an amount which it deems appropriate.

    (b)              Bonuses.  ▇▇. ▇▇▇▇▇▇ shall be eligible to receive with respect to each Fiscal Year during the Employment Term bonuses under the Company’s bonus program, if any, which may be subsequently adopted or amended by the Compensation Committee (“Compensation Committee”) of the Board of Directors (or the full Board as the case may be). The Company’s current bonus program for ▇▇. ▇▇▇▇▇▇ is set forth on Exhibit A which is attached hereto and incorporated herein by this reference.

    (c)              Stock Options and Restricted Stock Grants.  ▇▇. ▇▇▇▇▇▇ shall receive such options to purchase the common stock of the Company, or such grants of restricted stock of the Company, if any, as shall be granted by the Compensation Committee, in its discretion, pursuant to the Company’s 1999 Omnibus Stock Incentive Plan or any other stock option plan which may be applicable.

    (d)              Fringe Benefits.  During the Employment Term, ▇▇. ▇▇▇▇▇▇ shall be eligible to receive reasonable amounts of paid, non-cumulative vacation per year, to be taken at a time or times reasonably agreeable to both ▇▇. ▇▇▇▇▇▇ and the Company, and shall be eligible to participate in and receive coverage and benefits under all group insurance, pension, profit sharing, bonus, stock option, stock ownership and other employee benefit plans, programs and arrangements of Sento which are now or hereafter adopted by Sento for the benefit of its similarly situated executive employees, subject to and on a basis consistent with the terms, conditions and overall administration of such plans, programs and arrangements.

    (e)               Business Expenses.  The Company shall reimburse ▇▇. ▇▇▇▇▇▇ for the reasonable and necessary business expenses incurred by ▇▇. ▇▇▇▇▇▇ in connection with the performance of his duties and obligations as set forth herein during the Employment Term. Such expenses shall include, but are not limited to, cellular telephone expenses and all expenses of travel and living expenses while away from home on business or at the request and in the service of the Company, provided that such expenses are properly incurred and accounted for in accordance with the applicable policies and procedures established by the Company. Reimbursement shall be made upon the presentation by ▇▇. ▇▇▇▇▇▇ to the Company of reasonably detailed statements of such expenses.

    (f)              Proration of Compensation.  Any compensation payable to ▇▇. ▇▇▇▇▇▇ under this Section 2 in respect of any Fiscal Year during which the Employment Term terminates prior to the last day of such Fiscal Year shall, unless otherwise provided in the applicable plan, program or arrangement, be prorated in accordance with the number of days in such Fiscal Year during which he is so employed.

    3.              Benefits Following Employment Term or Termination.  For the shorter of the following periods: (i) a period of twelve (12) months following the Date of Termination of the Employment Term, or (ii) a period from the Date of Termination of the Employment Term and continuing until the date ▇▇. ▇▇▇▇▇▇ accepts other employment with comparable benefits, and provided that ▇▇. ▇▇▇▇▇▇ was not terminated for cause as provided in Subsection (a) of Section 5 herein, the Company shall permit, at the Company’s expense, ▇▇. ▇▇▇▇▇▇, his spouse and dependents, as applicable (the “Benefit Participants”) to participate in all group medical and health insurance plans then made available to the executive employees of the Company (the “Plans”) (including but not limited to such Plans in which ▇▇. ▇▇▇▇▇▇ was entitled to participate immediately prior to the Date of Termination) in the same manner as provided to its other executive employees; provided, however, that this Section 3 shall not apply in the event that (i) Sento shall hereafter terminate the applicable Plan, or (ii) the participation of the Benefit Participants in such Plan is prohibited by law or, if applicable, would disqualify such Plan as a tax qualified plan pursuant to the Internal Revenue Code of 1986, as amended, or any successor thereto (the “Code”) or (iii) the participation of the Benefit Participants violates the general terms and provisions of such applicable Plan. In the event that any of the Benefit Participants’ participation in such Plans is prohibited by law or, if applicable, would disqualify the Plan as a tax qualified plan, the Company shall pay the monthly COBRA premiums otherwise payable by ▇▇. ▇▇▇▇▇▇ with respect to continuation coverage of such Plans or permit the Benefit Participants to acquire substantially comparable coverage at the Company’s expense, from a source of ▇▇. ▇▇▇▇▇▇’▇ or his spouse’s choosing, notwithstanding the fact that such coverage or benefit will result in a higher cost than if provided under an Sento Plan. However, in no event will the Benefit Participants receive from the Company the coverage contemplated by this Section 3 if the Benefit Participants receive such coverage from any other source.

    4.        Compensation upon Termination or During Disability.

    (a)              Compensation upon Termination for Cause.  If the Employment Term shall be terminated “for cause,” as provided in Subsection (a) of Section 5 herein, the Company shall have no further liability under this Agreement except to pay ▇▇. ▇▇▇▇▇▇ (i) the value of any accrued salary or other compensation due to ▇▇. ▇▇▇▇▇▇ pursuant to Section 2 herein (including any earned and awarded but unpaid bonus payment, subject to set-off of amounts owed to the Company, but excluding any deferred bonus payments based upon quarterly Fiscal Year performance) upon the date of delivery of Notice of Termination to ▇▇. ▇▇▇▇▇▇, at the rate in effect at the time such Notice of Termination is delivered, and (ii) any benefits payable under all employee benefit plans, programs and arrangements of Sento in which ▇▇. ▇▇▇▇▇▇ is a participant on the date of delivery of Notice of Termination.

    (b)              Compensation upon Death.  If the Employment Term is terminated by ▇▇. ▇▇▇▇▇▇’▇ death, the Company shall have no further liability under this Agreement except to pay ▇▇. ▇▇▇▇▇▇’▇ spouse, or if he leaves no spouse, his estate or devisee, legatee or other designee, as applicable, (i) the value of any accrued salary or other compensation due to ▇▇. ▇▇▇▇▇▇ pursuant to Section 2 herein (including any earned put unpaid bonus payment or prorata share of such earned bonus payment, but excluding deferred bonus payments based upon annual Fiscal Year performance) at the time of his death, (ii) any death benefit payable under all employee benefit plans, programs and arrangements of Sento in which ▇▇. ▇▇▇▇▇▇ is a participant on the date of his death, and (iii) any Plan coverage continuation for ▇▇. ▇▇▇▇▇▇’▇ spouse and dependents, as applicable, under Section 3 herein.

    (c)              Compensation upon Disability.  During any period that ▇▇. ▇▇▇▇▇▇ fails to perform his duties hereunder as a result of incapacity due to an “impaired condition,” as such term is defined in Subsection (c) of Section 5 herein (the “disability period”), ▇▇. ▇▇▇▇▇▇ shall continue to receive his full salary at the rate then in effect for the disability period until the Employment Term is terminated pursuant to Subsection (c) of Section 5 herein; provided, however, that such salary payments so made to ▇▇. ▇▇▇▇▇▇ pursuant hereto shall be reduced by the sum of the amounts, if any, payable to ▇▇. ▇▇▇▇▇▇ prior to or during this period, as the result of such incapacity, under any disability benefit plan or insurance program of Sento in which ▇▇. ▇▇▇▇▇▇ participates.

    In the event of termination of the Employment Term pursuant to Subsection (c) (disability) of Section 5 herein, the Company shall have no further responsibilities under this Agreement except (i) to pay the value of any accrued salary or other compensation due under Section 2 herein (including any earned but unpaid bonus payment or prorata share of such earned bonus payment, but excluding deferred bonus payments based upon annual Fiscal Year performance) on the Date of Termination to ▇▇. ▇▇▇▇▇▇ (or in the event of ▇▇. ▇▇▇▇▇▇’▇ subsequent death, to his estate or devisee, legatee or other designee, as applicable), together with any benefits payable under all employee benefit plans, programs or arrangements of Sento in which ▇▇. ▇▇▇▇▇▇ is a participant on the Date of Termination, and (ii) to provide for any Plan coverage continuation for ▇▇. ▇▇▇▇▇▇, his spouse and dependents, as applicable under Section 3 herein.

    (d)              Compensation upon Termination by ▇▇. ▇▇▇▇▇▇.  If ▇▇. ▇▇▇▇▇▇ terminates the Employment Term due to “impaired health” or for Good Reason, as such terms are defined in Subsection (d) of Section 5 herein, the Company shall have no further responsibility under this Agreement except (i) to pay the value of any accrued salary or other compensation due under Section 2 herein (including any earned but unpaid bonus payment or prorata share of such earned bonus payment, but excluding deferred bonus payments based upon annual Fiscal Year performance) on the Date of Termination to ▇▇. ▇▇▇▇▇▇ (or in the event of ▇▇. ▇▇▇▇▇▇’▇ subsequent death, to his estate or devisee, legatee or other designee, as appropriate), together with any benefits payable under all employee benefit plans, programs or arrangements of Sento in which ▇▇. ▇▇▇▇▇▇ is a participant on the Date of Termination, (ii) to pay the value of any severance compensation owed to ▇▇. ▇▇▇▇▇▇ (or in the event of ▇▇. ▇▇▇▇▇▇’▇ subsequent death, to his estate or devisee, legatee or other designee, as appropriate) as set forth in Subsection (f) of this Section 4 (which shall survive the termination of the Employment Term), and (iii) to provide for any Plan coverage continuation for ▇▇. ▇▇▇▇▇▇, his spouse and dependents, as applicable, under Section 3 herein.

    (e)              Compensation upon Termination by Company.  If the Company breaches this Agreement by terminating the Employment Term, other than pursuant to Subsections (a) (cause), (b) (death), or (c) (disability) of Section 5 herein, including but not limited to termination without “cause” (as such term is defined in Subsection (a) of Section 5 herein), the Company shall (i) pay the value of any accrued salary or other compensation due under Section 2 herein (including any earned but unpaid bonus payment or prorata share of such earned bonus payment, but excluding deferred bonus payments based upon annual Fiscal Year performance) on the Date of Termination to ▇▇. ▇▇▇▇▇▇ (or in the event of ▇▇. ▇▇▇▇▇▇’▇ subsequent death, to his estate or devisee, legatee or other designee, as appropriate), together with any benefits payable under all employee benefit plans, programs or arrangements of Sento in which ▇▇. ▇▇▇▇▇▇ is a participant on the Date of Termination, (ii) pay the value of any severance compensation owed to ▇▇. ▇▇▇▇▇▇ (or in the event of ▇▇. ▇▇▇▇▇▇’▇ subsequent death, to his estate or devisee, legatee or other designee, as appropriate) as set forth in Subsection (f) of this Section 4 (which shall survive the termination of the Employment Term), and (iii) provide for any Plan coverage continuation for ▇▇. ▇▇▇▇▇▇, his spouse and dependents, as applicable, under Section 3 herein.

    (f)        Severance Compensation.

    (i)       Termination by Company or by ▇▇. ▇▇▇▇▇▇ for Good Reason.  If, during the first year of this Agreement, the Company breaches this Agreement by terminating the Employment Term other than pursuant to Subsections (a) (cause), (b) (death), or (c) (disability) of Section 5 herein, including but not limited to termination without “cause” (as such term is defined in Subsection (a) of Section 5 herein), or if ▇▇. ▇▇▇▇▇▇ terminates the Employment Term for Good Reason, as such term is defined in Subsection (d)(i) of Section 5 herein (other than due to a Change in Control, as hereinafter defined), then the Company shall pay as severance compensation to ▇▇. ▇▇▇▇▇▇ an amount equal to three (3) months of ▇▇. ▇▇▇▇▇▇’▇ annual base salary in effect as of the Date of Termination, payable by continuing ▇▇. ▇▇▇▇▇▇’▇ regular salary at the regular bi-weekly payment intervals for a period of thirteen weeks after the Date of Termination or after notice of non-extension by the Company, until the aggregate amount payable has been paid. If, after the first year of this Agreement, the Company breaches this Agreement by terminating the Employment Term other than pursuant to Subsections (a) (cause), (b) (death), or (c) (disability) of Section 5 herein, including but not limited to termination without “cause” (as such term is defined in Subsection (a) of Section 5 herein), or if ▇▇. ▇▇▇▇▇▇ terminates the Employment Term for Good Reason, as such term is defined in Subsection (d)(i) of Section 5 herein (other than due to a Change in Control, as hereinafter defined), then the Company shall pay as severance compensation to ▇▇. ▇▇▇▇▇▇ an amount equal to one-half of ▇▇. ▇▇▇▇▇▇’▇ annual base salary in effect as of the Date of Termination, payable by continuing ▇▇. ▇▇▇▇▇▇’▇ regular salary at the regular bi-weekly payment intervals for a period of twenty-six weeks after the Date of Termination, until the aggregate amount payable has been paid. Such severance compensation shall not be subject to mitigation or offset due to other earnings of ▇▇. ▇▇▇▇▇▇.

    (ii)       Termination Following a Change in Control.  If the Employment Term is terminated by ▇▇. ▇▇▇▇▇▇ or by the Company within one hundred eighty (180) days following a Change in Control, as such term is defined in Subsection (d)(ii) of Section 5 herein, then the Company shall pay as severance compensation to ▇▇. ▇▇▇▇▇▇ an amount equal to one-half of ▇▇. ▇▇▇▇▇▇’▇ annual base salary in effect as of the Date of Termination. Such severance compensation shall be payable by continuing ▇▇. ▇▇▇▇▇▇’▇ regular salary at the regular bi-weekly payment intervals for a period of twenty six weeks after the Date of Termination, until the aggregate amount payable has been paid. Such severance compensation shall be subject to mitigation or offset due to other earnings of ▇▇. ▇▇▇▇▇▇.

    5.       Termination.

    (a)       Cause.  The Employment Term may be terminated at any time at the option of the Company “for cause” (as such term is hereinafter defined), effective upon the giving of written notice of termination to ▇▇. ▇▇▇▇▇▇. As used herein, the term “for cause” shall mean and be limited to: (i) any felony conviction, (ii) willful misconduct or gross negligence in connection with the performance of ▇▇. ▇▇▇▇▇▇’▇ duties, responsibilities, agreements and covenants hereunder, which shall continue for a period of thirty (30) days after the receipt of notice from the Company, (iii) refusal to comply with reasonable rules, regulations, policies, directions and restrictions as may be established from time to time by the Board of Directors of Sento, whereby such refusal continues for thirty (30) days after the receipt of notice from the Company, or (iv) repeated abuse (following at least one written warning from the Company) of alcohol or any illegal use of narcotics or other controlled substances. If ▇▇. ▇▇▇▇▇▇ is advised that he is being terminated for cause, he may submit to the Board of Directors of Sento a written objection to such determination.

    (b)       Death.  The Employment Term shall terminate automatically upon the death of ▇▇. ▇▇▇▇▇▇.

    (c)       Disability.  In the event ▇▇. ▇▇▇▇▇▇ becomes mentally or physically “disabled” during the Employment Term, the Employment Term shall terminate on the Date of Termination (as such term is defined in Subsection (f) of this Section 5) once the disability is “established.” As used in this Subsection, the term “disabled” means suffering from any mental or physical condition, other than that resulting from the use of alcohol or illegal use of narcotics or other controlled substances, which renders ▇▇. ▇▇▇▇▇▇ unable to substantially perform all of his material duties and services under this Agreement in a satisfactory manner (an “impaired condition”) for a period of one hundred twenty (120) consecutive days or for more than one hundred eighty (180) days in any twelve (12) month period. For purposes of this Subsection, the date that ▇▇. ▇▇▇▇▇▇’▇ disability is “established” shall be, in the case of an impaired condition which exists for a period of one hundred twenty (120) consecutive days, the one hundred twenty-first (121^st) day on which such impaired condition exists, and, in the case of an impaired condition existing for more than one hundred eighty (180) days in any twelve (12) month period, the one hundred eighty-first (181^st) day on which such impaired condition exists.

    (d)       Termination by ▇▇. ▇▇▇▇▇▇.  ▇▇. ▇▇▇▇▇▇ may terminate the Employment Term (1) for Good Reason, or (2) if his health should become impaired to an extent that makes his continued performance of his duties and obligations hereunder hazardous to his physical or mental health or his life (“impaired health”), provided that ▇▇. ▇▇▇▇▇▇ shall have furnished the Company with a written statement from a qualified doctor to such effect and provided further that, at the Company’s request, ▇▇. ▇▇▇▇▇▇ shall submit to an examination by a doctor selected by the Company and such doctor shall have concurred in the conclusion of ▇▇. ▇▇▇▇▇▇’▇ doctor, or (3) voluntarily, without Good Reason and not due to “impaired health.” In the event that ▇▇. ▇▇▇▇▇▇ voluntarily terminates the Employment Term without Good Reason and not due to “impaired health,” such termination shall be treated as if it were a termination “for cause” by the Company.

    (i)       Good Reason Defined.  For purposes of this Agreement, “Good Reason” shall mean:

    a.         a Change in Control of the Company(as defined in Subsection (d)(ii) below);

    b.         a failure by the Company to comply with any material provision of this Agreement which has not been cured within thirty (30) days after written notice of such noncompliance has been given by ▇▇. ▇▇▇▇▇▇ to the Company; or

    c.         any purported termination of ▇▇. ▇▇▇▇▇▇’▇ employment which is not effected pursuant to a Notice of Termination satisfying the requirements of Subsection (e) of this Section 5 (and for purposes of this Agreement no such purported termination shall be effective);

    d.         a change in ▇▇. ▇▇▇▇▇▇’▇ title or duties which are in material respects inconsistent with ▇▇. ▇▇▇▇▇▇’▇ position as set forth in Section 1(c);

    e.        a required move of ▇▇. ▇▇▇▇▇▇’▇ residence to a location that is more than 50 miles from his existing residence.

    (ii)           Change in Control Defined. A “Change in Control” shall be deemed to have occurred:

    a.         upon any “person” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) (other than any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of common stock of the Company), becoming the owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing twenty-five percent (25%) or more of the combined voting power of the Company’s then outstanding securities;  

    b.        if, during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in paragraph (a), (c) or (d) of this Subsection or a director whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or contests by or on behalf of a person other than the Board of Directors of the Company) whose election by the Board of Directors or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board of Directors;  

    c.        upon the merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity (which entity shall thereafter be the “Company” as defined herein) outstanding immediately after such merger or consolidation; provided, however, that a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no person (other than those covered by the exceptions in (a) above) acquires more than twenty-five percent (25%) of the combined voting power of the Company’s then outstanding securities shall not constitute a Change of Control of the Company; or  

    d.        if the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets other than the sale of all or substantially all of the assets of the Company to a person or persons who beneficially own, directly or indirectly, at least fifty percent (50%) or more of the combined voting power of the outstanding voting securities of the Company at the time of the sale.  

    (e)       Notice of Termination.  Any termination of the Employment Term by the Company or by ▇▇. ▇▇▇▇▇▇ (other than termination pursuant to Subsection (b) (death) of this Section 5) shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Employment Term under the Section and Subsection so indicated.

    (f)        Date of Termination.  “Date of Termination” shall mean the following, respectively, if the Employment Term is terminated by: (i) Subsection (a) (cause) of this Section 5, the date specified in the Notice of Termination, (ii) Subsection (b) (death) of this Section 5, the date of ▇▇. ▇▇▇▇▇▇’▇ death, (iii) Subsection (c) (disability) of this Section 5, thirty (30) days after Notice of Termination is given (provided that ▇▇. ▇▇▇▇▇▇ shall not have returned to the satisfactory performance of his duties on a full-time basis during such thirty (30) day period), and (iv) if for any other reason, the date on which a Notice of Termination is given.  

    6.       Other Business Activities.  During the Employment Term and continuing thereafter for the period during which severance compensation is being paid, ▇▇. ▇▇▇▇▇▇ shall not, without the prior written authorization of the Board of Directors of the Company, directly or indirectly render services of a business, professional or commercial nature (whether for compensation or otherwise) to any person or entity competitive or adverse to Sento’s business welfare or engage in any activity whether alone, as a partner, or as an officer, director, employee, consultant, independent contractor, or stockholder in any other corporation, person, or entity which is competitive with or adverse to Sento’s business welfare. This Section 6 shall not, however, prevent ▇▇. ▇▇▇▇▇▇ from investing in securities issued by any such competitive or adverse corporation, provided the holdings thereof by ▇▇. ▇▇▇▇▇▇ do not constitute more than five percent (5%) of any one class of such securities. The Company covenants and agrees that it will not assert the “inevitable disclosure doctrine” primarily in an attempt to lengthen the term of the non-competition covenant of ▇▇. ▇▇▇▇▇▇ as set forth in this Section 6.

    7.       Confidential Information.

    (a)       Disclosure and Use.  ▇▇. ▇▇▇▇▇▇ shall not disclose or use at any time, either during or subsequent to the Employment Term, any trade secrets or other confidential information, whether patentable or not, of Sento, including but not limited to, any technical or non-technical data, any formula, pattern, compilation, program, device, method, technique, drawing, process, financial data, or any list of actual or potential customers or suppliers, of which ▇▇. ▇▇▇▇▇▇ is or becomes informed or aware during the Employment Term, whether or not developed by ▇▇. ▇▇▇▇▇▇, except (i) as may be reasonably required for ▇▇. ▇▇▇▇▇▇ to perform ▇▇. ▇▇▇▇▇▇’▇ employment duties with the Company, (ii) to the extent such information becomes generally available to the public through no wrongful act of ▇▇. ▇▇▇▇▇▇, (iii) information which has been disclosed as a result of a subpoena or other legal process, provided that ▇▇. ▇▇▇▇▇▇ has provided the Company with prompt written notice of the receipt thereof, or (iv) unless ▇▇. ▇▇▇▇▇▇ shall first secure the Company’s prior written authorization. This covenant shall survive the termination of ▇▇. ▇▇▇▇▇▇’▇ employment hereunder, and shall remain in effect and be enforceable against ▇▇. ▇▇▇▇▇▇ for so long as any such Sento secret or confidential information retains economic value, whether actual or potential, from not being generally known to other persons who can obtain economic value from its disclosure or use. ▇▇. ▇▇▇▇▇▇ agrees to execute such further agreements and/or confirmations of ▇▇. ▇▇▇▇▇▇’▇ obligations to Sento concerning non-disclosure of Sento trade secrets and confidential information as Sento may reasonably require from time to time.

    (b)       Return of Materials.  Upon termination of the Employment Term, ▇▇. ▇▇▇▇▇▇ (or in the event of termination due to ▇▇. ▇▇▇▇▇▇’▇ death, his estate or devisee, legatee or other designee, as applicable) shall promptly deliver to the Company all materials of a secret or confidential nature relating to Sento’s business which are in the possession or under the control of ▇▇. ▇▇▇▇▇▇.

    8.       Inventions and Discoveries.  ▇▇. ▇▇▇▇▇▇ hereby assigns to the Company or its designee all of ▇▇. ▇▇▇▇▇▇’▇ rights, title and interest in and to all inventions, discoveries, processes, designs, works of authorship and other intellectual property and all improvements on existing inventions, discoveries, processes, designs, works and other intellectual property made or discovered by ▇▇. ▇▇▇▇▇▇ during the Employment Term. Promptly upon the development, making, creation, or discovery of any invention, discovery, process, design, work, intellectual property or improvement, ▇▇. ▇▇▇▇▇▇ shall disclose the same to the Company and shall execute and deliver to the Company or its designee such reasonable documents as the Company may request to confirm the assignment of ▇▇. ▇▇▇▇▇▇’▇ rights therein, and if requested by the Company, shall assist the Company or its designee in applying for and prosecuting any patents and any trademark or copyright registration which may be available in respect thereof. Any invention, discovery or other work for which none of Sento’s equipment, supplies, facilities, or confidential information was used and which was developed entirely on ▇▇. ▇▇▇▇▇▇’▇ own time, is exempted from this Section 8 so long as it (i) does not relate in any way to Sento’s business, or actual or demonstrably anticipated research and development; and (ii) does not result in any way from ▇▇. ▇▇▇▇▇▇’▇ work for the Company.

    9.       Severability.  If any provision of this Agreement is held invalid or unenforceable, either in its entirety or by virtue of its scope or application to given circumstances, such provision shall thereupon be deemed (i) modified only to the extent necessary to render the same valid, or (ii) not applicable to given circumstances, or (iii) excised from this Agreement, as the situation may require, and this Agreement shall be construed and enforced as if such provision had been included herein as so modified in scope or application, or had not been included herein, as the case may be.

    10.       Enforcement.  The Company will be entitled to institute proceedings and avail itself of all remedies at law or in equity to recover damages occasioned by a breach or threatened breach of any of the provisions of this Agreement by ▇▇. ▇▇▇▇▇▇ and shall have the right to pursue one or more of such proceedings and remedies simultaneously or from time to time. ▇▇. ▇▇▇▇▇▇ hereby acknowledges that the Company would suffer irreparable injury if the provisions of Sections 6, 7 and 8 herein, which shall survive the termination of this Agreement, were breached and that the Company’s remedies at law would be inadequate in the event of such breach or threatened breach. Accordingly, ▇▇. ▇▇▇▇▇▇ hereby agrees that any such breach or threatened breach may, in addition to any and all other available remedies, be preliminarily and permanently enjoined by any court of competent jurisdiction without any requirement that the Company post a bond.

    11.       Legal Fees and Expenses.  In the event of litigation proceedings under this Agreement, both the Company and ▇▇. ▇▇▇▇▇▇ shall pay their own attorneys’ fees and other legal expenses and costs.

    12.       General Provisions.

    (a)              Notices.  Any notice, request, demand or other communication required or permitted to be given hereunder shall be in writing and personally delivered or sent by registered or certified mail, return receipt requested, or by a facsimile, telegram or telex followed by a confirmation letter sent by registered or certified mail, return receipt requested, addressed as follows:

    (b)              Amendments.  Neither this Agreement nor any of the terms or conditions hereof may be waived, amended or modified except by means of a written instrument duly executed by the party to be charged therewith.

    (c)              Captions and Headings.  The captions and Section headings used in this Agreement are for convenience of reference only, and shall not affect the construction or interpretation of this Agreement or any of the provisions hereof.

    (d)              Governing Law.  This Agreement, and all matters or disputes relating to the validity, construction, performance or enforcement hereof, shall be governed, construed and controlled by and under the laws of the State of Utah without regard to principles of conflicts of law.

    (e)              Successors and Assigns.  In light of the unique personal services to be performed by ▇▇. ▇▇▇▇▇▇ hereunder, it is acknowledged and agreed that any purported or attempted assignment or transfer by ▇▇. ▇▇▇▇▇▇ of this Agreement or any of ▇▇. ▇▇▇▇▇▇’▇ duties, responsibilities, or obligations hereunder shall be void. The Company shall not assign this Agreement to any third party entity which is not affiliated with the Company or any of its direct or indirect subsidiaries. Subject to the foregoing, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs, executors, administrators, personal representatives, successors and permitted assigns.

    (f)              Counterparts.  This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original hereof, but all of which together shall constitute one and the same Instrument.

    (g)              Entire Agreement.  Except as otherwise set forth or referred to in this Agreement, this Agreement constitutes the sole and entire agreement and understanding between the parties hereto as to the subject matter hereof and supersedes all prior discussions, agreements and understandings of every kind and nature between them as to such subject matter.

    (h)              Reliance by Third Parties.  This Agreement is intended for the sole and exclusive benefit of the parties hereto and their respective heirs, executors, administrators, personal representatives, successors and permitted assigns, and no other person or entity shall have any right to rely on this Agreement or to claim or derive any benefit therefrom absent the express written consent of the party to be charged with such reliance or benefit.